Skip to main content
. 2021 Jun;10(6):2725–2737. doi: 10.21037/tcr-21-236

Figure 1.

Figure 1

Annotation of A-to-I RNA editing sites. These are non-redundant sites which are obtained from the union of sites in ten patients, tumor and normal, RNA-seq and ribo-seq. (A) Pie chart showing the fractions of each type of site; (B) the abundance of sites in CDS and 5’UTR; (C) the fraction of Alu and non-Alu editing sites; (D) the annotation of editing sites regarding Alu and non-Alu.